Recent partnership announcements in the pharma industry reflects the community’s commitment to collaborative innovation, ...

In 2022, the combined research and development (R&D) expenditure of the U.S. pharmaceutical industry consisted of more than $100 billion. While this is a significantly expansive market, approximately ...

In 2025, landmark obesity drug deals, China’s biotech surge, and AI’s deeper integration into pharma operations drove a year ...

Pharma’s return on investment (ROI) for research and development (R&D) is seeing a comeback after a record low in 2022, according to a recent report out of Deloitte. ROI on pharma R&D jumped to 4.1% ...

Miami, FL — Silvio Pereira Junior, CEO & Founder of FPG Brands, shares insights on how the U.S. pharmaceutical industry can dominate emerging markets globally. The U.S. pharmaceutical industry, a ...

insights from industrySree VadlamudiVice President, Head of Business Development EU, RoWIktos As part of our SLAS Europe 2022 coverage, we speak to Dr. Sree Vadlamudi, Vice President BD at Iktos, ...

Editor's note: this interview was originally published on BioPharmInternational.com.

If you want a large pharmaceutical company to invent a new drug, your best bet is probably AstraZeneca. But if you have a medicine you’d like to get to market — and you want to see it generate revenue ...

Tariffs increase operational costs by raising prices for raw materials, APIs, and finished drugs, complicating logistics and ...

LONDON--(BUSINESS WIRE)--SpendEdge, a leading provider of procurement market intelligence solutions, has announced the completion of their latest article on the imperative need of the procurement ...